or
forgot password

    • cancer clinical trials in somerset, NJ

    • Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
    Somerset Hematology Oncology Associates
    Somerset, New Jersey 08873
    B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    Somerset Hematology Oncology Associates
    Somerset, New Jersey 08873
    Renal Cell Carcinoma
    Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
    Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2)
    Somerset, New Jersey 08873
    Relapsed and Bortezomib Refractory Multiple Myeloma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
    Registry Study for Proton Therapy Outcomes
    ProCure Proton Therapy Center
    Somerset, New Jersey 08873
    Solid Tumors
    Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
    Somerset Hematology Oncology Associates
    Somerset, New Jersey 08873
    Follicular Lymphoma
    Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
    Robert Wood Johnson Medical School/UMDNJ Department of Dermatology
    Somerset, New Jersey 08873
    Psoriasis, Psoriatic Arthritis
    Proton Radiation for Stage III Breast Cancer
    Princeton ProCure Managment LLC
    Somerset, New Jersey 08873
    Breast Cancer, Breast Neoplasm, Breast Tumor, Cancer of the Breast
    A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
    Princeton ProCure Management LLC
    Somerset, New Jersey 08873
    Lung Neoplasms
    Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    Somerset Hematology Oncology Associates
    Somerset, New Jersey 08873
    Non-small Cell Lung Cancer
    Non-small Cell Lung Cancer Registry
    Medical Hematology/Oncology
    Somerset, New Jersey 08873
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin
    Hematology and Oncology Group
    Somerset, New Jersey 08873
    Carcinoma of Unknown Primary
    Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients
    Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2)
    Somerset, New Jersey 08873
    Multiple Myeloma
    Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients
    Somerset Hematology Oncology Associates Somerset Hema Oncol Assoc (2)
    Somerset, New Jersey 08873
    First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis